212 related articles for article (PubMed ID: 31347930)
1. Novel 2-phenoxypyrido[3,2-
Hao X; Qi G; Ma H; Zhu C; Han Z
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1368-1372. PubMed ID: 31347930
[TBL] [Abstract][Full Text] [Related]
2. A series of pyrido[2,3-b]pyrazin-3(4H)-one derivatives as aldose reductase inhibitors with antioxidant activity.
Han Z; Hao X; Ma B; Zhu C
Eur J Med Chem; 2016 Oct; 121():308-317. PubMed ID: 27267001
[TBL] [Abstract][Full Text] [Related]
3. Novel 3,4-dihydroquinolin-2(1H)-one derivatives as dual inhibitor targeting AKR1B1/ROS for treatment of diabetic complications: Design, synthesis and biological evaluation.
Han Z; Qi G; Zhu J; Zhang Y; Xu Y; Yan K; Zhu C; Hao X
Bioorg Chem; 2020 Dec; 105():104428. PubMed ID: 33161249
[TBL] [Abstract][Full Text] [Related]
4. Identification of quinoxalin-2(1
Hao X; Qin X; Zhang X; Ma B; Qi G; Yu T; Han Z; Zhu C
Future Med Chem; 2019 Dec; 11(23):2989-3004. PubMed ID: 31659919
[No Abstract] [Full Text] [Related]
5. Dihydrobenzoxazinone derivatives as aldose reductase inhibitors with antioxidant activity.
Chen H; Zhang X; Zhang X; Fan Z; Liu W; Lei Y; Zhu C; Ma B
Bioorg Med Chem; 2020 Oct; 28(20):115699. PubMed ID: 33069078
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity relationship studies of phenolic hydroxyl derivatives based on quinoxalinone as aldose reductase inhibitors with antioxidant activity.
Hao X; Han Z; Li Y; Li C; Wang X; Zhang X; Yang Q; Ma B; Zhu C
Bioorg Med Chem Lett; 2017 Feb; 27(4):887-892. PubMed ID: 28109789
[TBL] [Abstract][Full Text] [Related]
7. Phenolic 4-hydroxy and 3,5-dihydroxy derivatives of 3-phenoxyquinoxalin-2(1H)-one as potent aldose reductase inhibitors with antioxidant activity.
Zou Y; Qin X; Hao X; Zhang W; Yang S; Yang Y; Han Z; Ma B; Zhu C
Bioorg Med Chem Lett; 2015 Sep; 25(18):3924-7. PubMed ID: 26227780
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of potent and multifunctional aldose reductase inhibitors based on quinoxalinones.
Qin X; Hao X; Han H; Zhu S; Yang Y; Wu B; Hussain S; Parveen S; Jing C; Ma B; Zhu C
J Med Chem; 2015 Feb; 58(3):1254-67. PubMed ID: 25602762
[TBL] [Abstract][Full Text] [Related]
9. Designing of acyl sulphonamide based quinoxalinones as multifunctional aldose reductase inhibitors.
Ji Y; Chen X; Chen H; Zhang X; Fan Z; Xie L; Ma B; Zhu C
Bioorg Med Chem; 2019 Apr; 27(8):1658-1669. PubMed ID: 30858026
[TBL] [Abstract][Full Text] [Related]
10. Exploiting oxadiazole-sulfonamide hybrids as new structural leads to combat diabetic complications via aldose reductase inhibition.
Javid N; Munir R; Chaudhry F; Imran A; Zaib S; Muzaffar A; Iqbal J
Bioorg Chem; 2020 Jun; 99():103852. PubMed ID: 32325339
[TBL] [Abstract][Full Text] [Related]
11. (5-Hydroxy-4-oxo-2-styryl-4
Chen H; Zhang X; Zhang X; Liu W; Lei Y; Zhu C; Ma B
Molecules; 2020 Nov; 25(21):. PubMed ID: 33158254
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of benzothiadiazine derivatives exhibiting dual activity as aldose reductase inhibitors and antioxidant agents.
Zhu S; Hao X; Zhang S; Qin X; Chen X; Zhu C
Bioorg Med Chem Lett; 2016 Jun; 26(12):2880-2885. PubMed ID: 27156769
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, structure-activity relationships and X-ray structural studies of novel 1-oxopyrimido[4,5-c]quinoline-2-acetic acid derivatives as selective and potent inhibitors of human aldose reductase.
Crespo I; Giménez-Dejoz J; Porté S; Cousido-Siah A; Mitschler A; Podjarny A; Pratsinis H; Kletsas D; Parés X; Ruiz FX; Metwally K; Farrés J
Eur J Med Chem; 2018 May; 152():160-174. PubMed ID: 29705708
[TBL] [Abstract][Full Text] [Related]
14. Pyridothiadiazine derivatives as aldose reductase inhibitors having antioxidant activity.
Zhu S; Zhang S; Hao X; Qin X; Parveen S; Yang S; Ma B; Zhu C
J Enzyme Inhib Med Chem; 2016; 31(sup1):126-130. PubMed ID: 27153454
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of N-(3,5-difluoro-4-hydroxyphenyl)benzenesulfonamides as aldose reductase inhibitors.
Alexiou P; Nicolaou I; Stefek M; Kristl A; Demopoulos VJ
Bioorg Med Chem; 2008 Apr; 16(7):3926-32. PubMed ID: 18267362
[TBL] [Abstract][Full Text] [Related]
16. Substituted derivatives of indole acetic acid as aldose reductase inhibitors with antioxidant activity: structure-activity relationship.
Juskova M; Majekova M; Demopoulos V; Stefek M
Gen Physiol Biophys; 2011 Dec; 30(4):342-9. PubMed ID: 22131315
[TBL] [Abstract][Full Text] [Related]
17. Coumarin-thiazole and -oxadiazole derivatives: Synthesis, bioactivity and docking studies for aldose/aldehyde reductase inhibitors.
Ibrar A; Tehseen Y; Khan I; Hameed A; Saeed A; Furtmann N; Bajorath J; Iqbal J
Bioorg Chem; 2016 Oct; 68():177-86. PubMed ID: 27544072
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of novel quinazolin-4(1H)-one derivatives as potent and selective inhibitors targeting AKR1B1.
Han Z; Li J; Xu Z; Su Y; Wang Y; Zhuo L; Du J; Zhu C; Hao X
Arch Pharm (Weinheim); 2023 Apr; 356(4):e2200577. PubMed ID: 36707406
[TBL] [Abstract][Full Text] [Related]
19. Novel synthesis of nitro-quinoxalinone derivatives as aldose reductase inhibitors.
Hussain S; Parveen S; Qin X; Hao X; Zhang S; Chen X; Zhu C; Ma B
Bioorg Med Chem Lett; 2014 May; 24(9):2086-9. PubMed ID: 24726808
[TBL] [Abstract][Full Text] [Related]
20. Identification of new potent inhibitor of aldose reductase from Ocimum basilicum.
Bhatti HA; Tehseen Y; Maryam K; Uroos M; Siddiqui BS; Hameed A; Iqbal J
Bioorg Chem; 2017 Dec; 75():62-70. PubMed ID: 28917123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]